Immunotech Biopharm Ltd (06978.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 0.39

From 52W high−92.15%

Volume70000.00

Market capHKD 230.58M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

HKD 0.39

From 52W high

−92.15%

Volume

70000.00

Market cap

HKD 230.58M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2.2x

P/E (TTM)

—

RSI (14)

53.6

MomentumView details →

1D Return

+1.20%

YTD Return

−85.67%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−2.2x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

−2.4x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

201.59%

ROA (TTM)

−35.20%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+34.88%

FCF YoY

+47.45%

Revenue CAGR 3Y

—

EPS CAGR 3Y

−16.67%

EBITDA YoY

+13.78%

MomentumView details →

1D Return

+1.20%

YTD Return

−85.67%

1Y Return

−91.21%

RSI (14)

53.6

vs 50D SMA

+0.12%

vs 200D SMA

−75.22%

Capital & dividendView details →

Debt/Equity

−1.20x

Current Ratio

0.22x

Quick Ratio

0.21x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−HKD 0.13

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−392.39M

Op. CF (TTM)

−153.31M

Next earningsMar 19, 2027 →

Latest newsMore news →

Yongtai Biological (06978.HK) reported interim results for the six months ended June 2026, with other income of RMB 12.6 million, down 3.4% year-on-year, and a narrowed net loss of RMB 69.87 million from RMB 129 million a year earlier, with a loss per share of RMB 0.11, and no dividend declared.28d ago

Similar companies

YD Bio Limited Ordinary SharesYDES ALX Oncology Holdings Inc.ALXO I-MabIMAB Compugen Ltd.CGEN Niagen Bioscience IncNAGE Anavex Life Sciences Corp.AVXL Find similar companies →

Latest newsMore news →

Yongtai Biological (06978.HK) reported interim results for the six months ended June 2026, with other income of RMB 12.6 million, down 3.4% year-on-year, and a narrowed net loss of RMB 69.87 million from RMB 129 million a year earlier, with a loss per share of RMB 0.11, and no dividend declared.28d ago